YBX1 and breast carcinoma: 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate (DPI) has been shown to hinder YBX1 nuclear translocation and its downstream target genes, which in turn inhibits breast cancer cell proliferation, migration, invasion, and metastasis [272].